CME/CNE Lunch Symposium at the ACTRIMS Forum 2019

CME/CNE Lunch Symposium
at the ACTRIMS Forum 2019

Advanced Strategies to Improve Outcomes and Reduce Disability in Patients With Multiple Sclerosis

Date

Saturday, March 2nd, 2019
11:50am-1:05pm

Location

Hilton Anatole
Governors Lecture Hall
2201 N Stemmons Freeway
Dallas, TX 75207
Now Open

Target Audience

Neurologists, primary care physicians, internists, nurse practitioners, nurses, and other healthcare providers involved in the management of patients with MS

Program Overview

This CME/CNE lunch symposium during the ACTRIMS Forum 2019, led by Fred D. Lublin, MD will analyze therapeutic strategies for improving outcomes and reducing disability in patients with multiple sclerosis (MS). The expert faculty will discuss best practices for early detection and monitoring of disease therapy in the MS patient population. The faculty will debate optimal strategies for selecting and switching therapies in the MS landscape in an interactive panel format. Optimal methods for providing long-term comprehensive care and managing disease progression utilizing the interprofessional team will be reviewed. This CME/CNE program will provide clinicians with vital information for improving outcomes and quality of life in patients with multiple sclerosis.

Educational Objectives

  1. Apply the principles of early diagnosis and early intervention for the management of patients with MS
  2. Analyze the most recent evidence-based data of therapeutic options to treat patients with MS
  3. Develop optimal treatment strategies for the long-term management of disease progression and the reduction of disability

Agenda:

  1. The Important Role of Early Diagnosis and Early Intervention for the Management of Patients with MS
  2. Update on the Most Recent Evidence-based Data of Therapeutic Options in MS
  3. Advanced Treatment Plans for the Long-Term management of Disease Progression and the Reduction of Disability

Accreditation Statements

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission (ANCC) on Accreditation. AcademicCME’s ANCC provider number is P0491.

Credit Designation Statements

AcademicCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 1.25 CNE contact hours.

CE Inquiries/Special Needs

For all CME/CNE inquiries or special needs, please contact [email protected] or 610-687-3300.

Financial Support

This activity has been supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

Provided by AcademicCME

screen-shot-2016-12-01-at-11-31-00-am

 

 

*This program is not part of the official ACTRIMS Forum 2019.


 

Please also join us for the Advanced Curriculum for Multiple Sclerosis, immediately before the ACTRIMS Forum on February 27th and 28th in the Hilton Anatole. The twenty six expert faculty, led by Fred D. Lublin, MD, will engage in vibrant and thorough discussion on current controversies in MS. The faculty will explore the principles of early diagnosis and early intervention in MS and how this can aid in optimizing treatment of patients with MS. They will review the most recent evidence-based data of therapeutic options to treat patients with MS as well as strategies for long-term management of disease progression. Through engagement with the audience, the faculty will enable learners to apply this information into their everyday practice and optimize their treatment of patients with MS.

For more information regarding this course, please visit: https://academiccme.com/dallas2019/

Chair:

Fred D. Lublin, MD
Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, New York

Faculty:

Joseph R. Berger, MD
Professor of Neurology and MS Division Chief
Department of Neurology, Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Jerry Wolinsky, MD
Director, MRI Analysis Center
Director, Multiple Sclerosis Research Group
University of Texas Medical School
Houston, Texas